FM
Family Management Portfolio holdings
AUM
$658M
This Quarter Return
+5.75%
1 Year Return
+14.42%
3 Year Return
+54.25%
5 Year Return
+91.79%
10 Year Return
+224.62%
AUM
$146M
AUM Growth
+$146M
(+0.39%)
Cap. Flow
-$5.15M
Cap. Flow
% of AUM
-3.53%
Top 10 Holdings %
Top 10 Hldgs %
44.05%
Holding
79
New
9
Increased
19
Reduced
28
Closed
12
Top Buys
| 1 |
Intel
INTC
|
$3.89M |
| 2 |
RTX Corp
RTX
|
$3.38M |
| 3 |
UnitedHealth
UNH
|
$2.52M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$351K |
| 5 |
McDonald's
MCD
|
$282K |
Top Sells
| 1 |
Cisco
CSCO
|
$4.58M |
| 2 |
GE Aerospace
GE
|
$4.07M |
| 3 |
Truist Financial
TFC
|
$2.43M |
| 4 |
Amazon
AMZN
|
$1.53M |
| 5 |
AGN
Allergan plc
AGN
|
$557K |
Sector Composition
| 1 | Technology | 20.96% |
| 2 | Financials | 16.22% |
| 3 | Healthcare | 14.94% |
| 4 | Communication Services | 12.38% |
| 5 | Energy | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
UnitedHealth
UNH
$279B
| $2.52M | 1.73% |
+12,885
| New | +$2.52M |
|
27
Kraft Heinz
KHC
$31.9B
| $2.38M | 1.63% |
30,640
-885
| -3% | -$68.6K |
|
28
Meta Platforms (Facebook)
META
$1.85T
| $1.97M | 1.35% |
11,537
+705
| +7% | +$120K |
|
|
RPT
29
Rithm Property Trust Inc.
RPT
$118M
| $1.29M | 0.88% |
91,209
+15,607
| +21% | +$220K |
|
30
Bristol-Myers Squibb
BMY
$96.7B
| $1.23M | 0.84% |
19,305
-1,850
| -9% | -$118K |
|
31
Acadia Pharmaceuticals
ACAD
$4.34B
| $1.11M | 0.76% |
29,500
-6,000
| -17% | -$226K |
|
32
Berkshire Hathaway Class A
BRK.A
$1.08T
| $824K | 0.56% |
3
-1
| -25% | -$275K |
|
|
33
Berkshire Hathaway Class B
BRK.B
$1.08T
| $777K | 0.53% |
4,240
-253
| -6% | -$46.4K |
|
|
NYMTO
34
DELISTED
New York Mortgage Trust, Inc. 7.875% Series C Cumulative Redeemable Preferred Stock
NYMTO
| $657K | 0.45% |
25,850
+4,430
| +21% | +$113K |
|
35
Abeona Therapeutics
ABEO
$357M
| $614K | 0.42% |
36,000
+12,000
| +50% | +$205K |
|
|
36
GE Aerospace
GE
$293B
| $533K | 0.37% |
22,025
-168,115
| -88% | -$4.07M |
|
37
DigitalBridge
DBRG
$2.05B
| $522K | 0.36% |
41,530
+7,844
| +23% | +$98.6K |
|
38
Lineage Cell Therapeutics
LCTX
$281M
| $518K | 0.35% |
182,350
+41,979
| +30% | +$119K |
|
39
Stryker
SYK
$149B
| $511K | 0.35% |
3,600
| – | – |
|
40
Pfizer
PFE
$141B
| $482K | 0.33% |
13,500
+2,950
| +28% | +$105K |
|
41
Target
TGT
$42B
| $475K | 0.33% |
8,050
+50
| +0.6% | +$2.95K |
|
42
Chevron
CVX
$318B
| $472K | 0.32% |
4,020
| – | – |
|
43
Philip Morris
PM
$254B
| $444K | 0.3% |
4,000
-692
| -15% | -$76.8K |
|
44
JPMorgan Chase
JPM
$824B
| $428K | 0.29% |
4,479
+1,400
| +45% | +$134K |
|
|
RDHL
45
Redhill Biopharma
RDHL
$2.94M
| $408K | 0.28% |
37,750
+12,000
| +47% | +$129K |
|
46
Alphabet (Google) Class C
GOOG
$2.79T
| $366K | 0.25% |
382
+65
| +21% | +$62.3K |
|
|
GBT
47
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $351K | 0.24% |
+11,300
| New | +$351K |
|
48
Enterprise Products Partners
EPD
$68.9B
| $351K | 0.24% |
13,461
+889
| +7% | +$23.2K |
|
49
AT&T
T
$208B
| $350K | 0.24% |
8,932
+11
| +0.1% | +$444 |
|
50
Merck
MRK
$210B
| $329K | 0.23% |
5,136
| – | – |
|